| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/29/1999 | CA2318221A1 Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 07/29/1999 | CA2318100A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2318088A1 Chemokine receptor antagonists and methods of use therefor |
| 07/29/1999 | CA2317839A1 Inhibition of cytokine production |
| 07/29/1999 | CA2317761A1 Thrombin inhibitors |
| 07/29/1999 | CA2317546A1 2,3,4,5-tetrahydro-1h-¬1,4|-benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors |
| 07/29/1999 | CA2284864A1 Dialkyl ureas as calcitonin mimetics |
| 07/28/1999 | EP0931788A2 Metalloprotease inhibitors |
| 07/28/1999 | EP0931549A2 Calcium/soy instant granulate and process for its preparation |
| 07/28/1999 | EP0931148A1 Fibroblast growth factor homologs |
| 07/28/1999 | EP0931091A1 Inhibitors of pla 2 |
| 07/28/1999 | EP0931087A1 Novel pyranoside derivatives |
| 07/28/1999 | EP0931086A1 Tetrahydronaphthalene derivatives and their therapeutic use |
| 07/28/1999 | EP0931075A1 Indazole derivatives and their use as inhibitors of phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 07/28/1999 | EP0931045A1 Matrix metalloproteinase inhibitors and their therapeutic uses |
| 07/28/1999 | CN1223877A Medicinal liquor for treatment of atrophic debility of bone and eliminating wind |
| 07/27/1999 | US5929120 Guainidino, formamidino, amino and related compounds for inhibiting osteoclast-mediated bone resorption |
| 07/27/1999 | US5929117 Immunotherapeutic agents |
| 07/27/1999 | US5929092 Lipophilic benzothiophenes for treating estrogen deficiency |
| 07/27/1999 | US5929056 Accesible from readily available starting materials to be used for wound healing and in cosmetics |
| 07/27/1999 | US5929029 Human calcium-binding phosphoprotein |
| 07/27/1999 | US5928940 Morphogen-responsive signal transducer and methods of use thereof |
| 07/22/1999 | WO1999036077A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/22/1999 | WO1999036069A1 Il-8 receptor antagonists |
| 07/22/1999 | WO1999030157A3 Neuropilins in methods for diagnosis and prognosis of cancer |
| 07/22/1999 | WO1999023208A3 RIBOZYMES TARGETED TO IL-15 mRNA |
| 07/22/1999 | CA2318195A1 Il-8 receptor antagonists |
| 07/22/1999 | CA2317813A1 Composition and method for treatment and prevention of arthritis and/or autoimmune diseases |
| 07/21/1999 | EP0930310A1 Isocoumarin derivatives and use thereof in drugs |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929571A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 07/21/1999 | EP0929565A2 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 07/21/1999 | EP0929554A1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists |
| 07/21/1999 | EP0929542A1 Compounds for and a method of inhibiting matrix metalloproteinases |
| 07/21/1999 | EP0929530A1 Quinazoline derivatives and pharmaceutical compositions containing them |
| 07/21/1999 | EP0929517A1 Hydroxamic acid derivatives |
| 07/21/1999 | EP0929516A1 Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect |
| 07/21/1999 | EP0929322A1 Methods and compositions for programming an organic matrix for remodeling into a target tissue |
| 07/21/1999 | EP0929312A1 Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression |
| 07/21/1999 | EP0929305A1 Use of vitamin d analogs for the treatment of arthritic disease |
| 07/21/1999 | EP0929302A1 Il-8 receptor antagonists |
| 07/21/1999 | EP0929295A1 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive |
| 07/21/1999 | EP0929270A1 Oral peptide pharmaceutical products |
| 07/21/1999 | EP0929216A1 Method of treating post menopausal diseases, including osteoporosis |
| 07/21/1999 | CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 07/21/1999 | CN1223651A Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 07/21/1999 | CN1223141A Liquor for treating rheumatism and arthritis |
| 07/21/1999 | CN1223134A Ointment for eliminating pain of spur and preparation process thereof |
| 07/21/1999 | CN1223131A Medicine for curing waist sprain and contusion |
| 07/15/1999 | WO1999035253A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035252A2 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035246A1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/15/1999 | WO1999035168A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035158A1 36 human secreted proteins |
| 07/15/1999 | WO1999035130A1 2,3-substituted indole compounds as cox-2 inhibitors |
| 07/15/1999 | WO1999035124A1 Matrix metalloprotease inhibitors |
| 07/15/1999 | WO1999035116A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments |
| 07/15/1999 | WO1999034784A2 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/15/1999 | WO1999034763A2 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis |
| 07/15/1999 | CA2317702A1 36 human secreted proteins |
| 07/15/1999 | CA2317382A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316973A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316864A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316863A1 2,3-substituted indole compounds as cox-2 inhibitors |
| 07/15/1999 | CA2245909A1 Novel compounds |
| 07/14/1999 | EP0928291A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 07/14/1999 | EP0928200A2 Therapeutic combinations of rar antagonists and rxr agonists |
| 07/14/1999 | EP0928197A1 Use of proteins as agents against autoimmune diseases |
| 07/14/1999 | EP0928194A1 Compositions and methods for administering integrin receptor antagonists |
| 07/14/1999 | CN1222917A Novel protein and process for producing the same |
| 07/14/1999 | CN1222509A New pyrrole compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/13/1999 | US5922761 Methods for in vivo reduction of iron levels and compositions useful therefor |
| 07/08/1999 | WO1999033994A1 Modified deacetoxycephalosporin c synthase (daocs) and x-ray structure |
| 07/08/1999 | WO1999033859A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 07/08/1999 | WO1999033834A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/08/1999 | WO1999033822A1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 07/08/1999 | WO1999033821A1 Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |
| 07/08/1999 | WO1999033799A1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 07/08/1999 | WO1999033415A1 Osteopontin-based compositions for enhancing bone repair |
| 07/08/1999 | WO1999025686B1 Cyclic amine derivatives and their use as drugs |
| 07/08/1999 | WO1999016406A3 Therapeutic method |
| 07/08/1999 | WO1999014231A3 Bifidus stimulating peptides and its uses |
| 07/08/1999 | CA2316401A1 Modified deacetoxycephalosporin c synthase (daocs) and x-ray structure |
| 07/08/1999 | CA2315723A1 Indole derivatives useful a.o. for the treatment of osteoporosis |
| 07/08/1999 | CA2315144A1 Novel farnesyl transferase inhibitors, preparation, pharmaceutical compositions containing them and use for preparing medicines |
| 07/07/1999 | EP0927758A2 Recombinant antibodies specific for TNF-Alpha |
| 07/07/1999 | EP0927257A2 Human protein kinases |
| 07/07/1999 | EP0927248A1 Secreted proteins and polynucleotides encoding them |
| 07/07/1999 | EP0927192A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/07/1999 | EP0927191A2 Anti-inflammatory peptides and uses thereof |
| 07/07/1999 | EP0927183A1 Spirocyclic metalloprotease inhibitors |
| 07/07/1999 | EP0927177A1 Novel benzothiophene derivatives, their preparation and use as urokinase inhibitors |
| 07/07/1999 | EP0927161A1 Substituted cyclic amine metalloprotease inhibitors |
| 07/07/1999 | EP0927156A1 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/07/1999 | EP0927150A1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 07/07/1999 | EP0927036A1 Transdermal therapeutical approach involving a combination of active substances containing oestriol |
| 07/07/1999 | EP0927029A1 Novel methods |
| 07/07/1999 | CN1222193A Extracellular matrix signalling molecules |
| 07/06/1999 | US5919809 3-substituted-2-oxindole derivatives |
| 07/06/1999 | US5919789 Xanthines and their therapeutic use |